David Haan

13.4k total citations
7 papers, 17 citations indexed

About

David Haan is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, David Haan has authored 7 papers receiving a total of 17 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cancer Research, 6 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in David Haan's work include Cancer Genomics and Diagnostics (7 papers), Pancreatic and Hepatic Oncology Research (4 papers) and Epigenetics and DNA Methylation (4 papers). David Haan is often cited by papers focused on Cancer Genomics and Diagnostics (7 papers), Pancreatic and Hepatic Oncology Research (4 papers) and Epigenetics and DNA Methylation (4 papers). David Haan collaborates with scholars based in United States and China. David Haan's co-authors include Gulfem D. Guler, Ioannis N. Anastopoulos, Alana S. Weinstein, Wayne Volkmuth, Verena Friedl, Anna Bergamaschi, Samuel Levy, Joshua M. Stuart, Christopher K. Wong and Tierney Phillips and has published in prestigious journals such as Journal of Clinical Oncology, PLoS Computational Biology and Journal of Molecular Diagnostics.

In The Last Decade

David Haan

6 papers receiving 15 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David Haan United States	3	12	9	9	2	2	7	17
Esther Pohl‐Rescigno Germany	2	13 1.1×	8 0.9×	11 1.2×	1 0.5×	3 1.5×	2	21
Diane Heditsian United States	3	8 0.7×	7 0.8×	7 0.8×	2 1.0×	2 1.0×	11	20
Eveline Chen United States	2	9 0.8×	6 0.7×	4 0.4×	2 1.0×	3 1.5×	4	12
Judit Kisistók Denmark	3	16 1.3×	16 1.8×	15 1.7×	3 1.5×	2 1.0×	4	26
Daniel Keliher United States	2	13 1.1×	9 1.0×	5 0.6×	2 1.0×	3 1.5×	5	18
Shu‐Qiang Liu China	3	12 1.0×	22 2.4×	8 0.9×	3 1.5×	2 1.0×	7	30
Rouven Hoefflin Germany	3	8 0.7×	10 1.1×	6 0.7×	2 1.0×	1 0.5×	3	18
Greg Gydush United States	2	9 0.8×	17 1.9×	9 1.0×	3 1.5×		3	24
Xueer Chen United States	3	9 0.8×	15 1.7×	7 0.8×	5 2.5×	2 1.0×	4	22
Jaime Guidry Auvil United States	3	6 0.5×	10 1.1×	6 0.7×	1 0.5×	4 2.0×	3	18

Countries citing papers authored by David Haan

Since Specialization

Citations

This map shows the geographic impact of David Haan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Haan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Haan more than expected).

Fields of papers citing papers by David Haan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Haan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Haan. The network helps show where David Haan may publish in the future.

Co-authorship network of co-authors of David Haan

This figure shows the co-authorship network connecting the top 25 collaborators of David Haan. A scholar is included among the top collaborators of David Haan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Haan. David Haan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Xue, Yuan, Glenn Oliveira, Verena Friedl, et al.. (2024). Analytical Validation of an Early Detection Pancreatic Cancer Test Using 5-Hydroxymethylation Signatures. Journal of Molecular Diagnostics. 26(10). 888–896. 4 indexed citations

2.

Bergamaschi, Anna, et al.. (2023). Early detection of pancreatic cancer using 5-hydroxymethylation profiles in plasma-derived cell-free DNA.. Journal of Clinical Oncology. 41(4_suppl). 672–672. 2 indexed citations

3.

Haan, David, Gulfem D. Guler, Anna Bergamaschi, Wayne Volkmuth, & Samuel Levy. (2022). Pancreatic cancer detection using 5-hydroxymethylation signatures in plasma-derived cell free DNA in high-risk patients with new onset diabetes.. Journal of Clinical Oncology. 40(4_suppl). 539–539. 2 indexed citations

4.

Fang, Lishan, Maria McSharry, David Haan, et al.. (2021). eVIP2: Expression-based variant impact phenotyping to predict the function of gene variants. PLoS Computational Biology. 17(7). e1009132–e1009132. 4 indexed citations

5.

Haan, David, Anna Bergamaschi, Yuhong Ning, et al.. (2021). Genome-wide 5hmC profiles to enable cancer detection and tissue of origin classification in breast, colorectal, lung, ovarian, and pancreatic cancers.. Journal of Clinical Oncology. 39(15_suppl). 3044–3044. 1 indexed citations

6.

Guler, Gulfem D., Anna Bergamaschi, David Haan, et al.. (2021). Pancreatic cancer detection using EpiDetect signatures in plasma-derived cell free DNA in high-risk patients with new onset diabetes.. Journal of Clinical Oncology. 39(15_suppl). e16265–e16265.

7.

Haan, David, Verena Friedl, Ioannis N. Anastopoulos, et al.. (2019). Using Transcriptional Signatures to Find Cancer Drivers with LURE. PubMed. 25. 343–354. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact